431 related articles for article (PubMed ID: 18455150)
1. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
Crèvecoeur J; Merville MP; Piette J; Gloire G
Biochem Pharmacol; 2008 Jun; 75(11):2183-91. PubMed ID: 18455150
[TBL] [Abstract][Full Text] [Related]
2. Theileria-induced constitutive IKK activation is independent of functional Hsp90.
Hermann P; Dobbelaere DA
FEBS Lett; 2006 Sep; 580(21):5023-8. PubMed ID: 16938294
[TBL] [Abstract][Full Text] [Related]
3. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK).
Qing G; Yan P; Xiao G
Cell Res; 2006 Nov; 16(11):895-901. PubMed ID: 17088896
[TBL] [Abstract][Full Text] [Related]
5. Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells.
Park KA; Byun HS; Won M; Yang KJ; Shin S; Piao L; Kim JM; Yoon WH; Junn E; Park J; Seok JH; Hur GM
Carcinogenesis; 2007 Jan; 28(1):71-80. PubMed ID: 16774932
[TBL] [Abstract][Full Text] [Related]
6. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
[TBL] [Abstract][Full Text] [Related]
7. Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages.
Hsu HY; Wu HL; Tan SK; Li VP; Wang WT; Hsu J; Cheng CH
Mol Pharmacol; 2007 Jan; 71(1):344-56. PubMed ID: 16868182
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cells.
Chun JK; Seo DW; Ahn SH; Park JH; You JS; Lee CH; Lee JC; Kim YK; Han JW
J Pharm Pharmacol; 2007 Apr; 59(4):561-6. PubMed ID: 17430640
[TBL] [Abstract][Full Text] [Related]
10. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
11. Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activation.
Yang M; Zhang H; Voyno-Yasenetskaya T; Ye RD
Mol Pharmacol; 2003 Aug; 64(2):447-55. PubMed ID: 12869650
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 maintains the tumour-like character of rheumatoid synovial cells by stabilizing integrin-linked kinase, extracellular signal-regulated kinase and protein kinase B.
Hashiramoto A; Murata M; Kawazoe T; Yoshida K; Akiyama C; Shiozawa K; Shiozawa S
Rheumatology (Oxford); 2011 May; 50(5):852-61. PubMed ID: 21177334
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation.
Koga F; Xu W; Karpova TS; McNally JG; Baron R; Neckers L
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11318-22. PubMed ID: 16844778
[TBL] [Abstract][Full Text] [Related]
15. Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis.
Kutuk O; Basaga H
Cytokine; 2004 Mar; 25(5):229-37. PubMed ID: 15036249
[TBL] [Abstract][Full Text] [Related]
16. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis.
Kim YK; Lee EK; Kang JK; Kim JA; You JS; Park JH; Seo DW; Hwang JW; Kim SN; Lee HY; Lee HW; Han JW
Cell Death Differ; 2006 Dec; 13(12):2033-41. PubMed ID: 16628233
[TBL] [Abstract][Full Text] [Related]
17. Geldanamycin inhibits NF-kappaB activation and interleukin-8 gene expression in cultured human respiratory epithelium.
Malhotra V; Shanley TP; Pittet JF; Welch WJ; Wong HR
Am J Respir Cell Mol Biol; 2001 Jul; 25(1):92-7. PubMed ID: 11472980
[TBL] [Abstract][Full Text] [Related]
18. Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation.
Broemer M; Krappmann D; Scheidereit C
Oncogene; 2004 Jul; 23(31):5378-86. PubMed ID: 15077173
[TBL] [Abstract][Full Text] [Related]
19. SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IkappaBalpha kinase activation.
Sethi G; Ahn KS; Sung B; Kunnumakkara AB; Chaturvedi MM; Aggarwal BB
Biochem Pharmacol; 2008 Dec; 76(11):1404-16. PubMed ID: 18606397
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation.
Qing G; Yan P; Qu Z; Liu H; Xiao G
Cell Res; 2007 Jun; 17(6):520-30. PubMed ID: 17563756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
